NASDAQ · Medical Care Facilities · USD
Nutex Health Inc. (NUTX) Stock Analysis
Nutex Health Inc. (NUTX) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
NUTX Key Statistics
As of Oct 21, 2026Trading
- Open
- $199.75
- Previous Close
- $198.99
- Day's Range
- 195.46–200.34
- 52-Week Range
- 83.99–226.16
- Volume
- 73.58K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 2.00
Valuation
- Market Cap
- $1.35B
- P/E Ratio
- 7.83
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 9.72
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.60
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 25.24
Financials (FY)
- Revenue (FY)
- $875.26M+82.36%
- Net Income (FY)
- $70.79M+35.88%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 21.25%
- Shares Outstanding
- 6.85M
- 1-Year Return
- +72.59%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 154.66K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, NUTX closed at $197.61, +72.59% over 1 year.
Nutex Health Inc. (NUTX) has a market capitalization of $1.35B.
In fiscal 2025, NUTX reported revenue of $875.26M.
NUTX Stock Return by Calendar Year
Nutex Health Inc. (NUTX) return since Apr 2022: what $10,000 became
- 1 year
- $10,000 $17,259
- +72.59%
- 3 years
- $10,000 $65,870
- +558.70%
- Since Apr 2022
- $10,000 $329
- −96.71%
If you had invested $10,000 in Nutex Health Inc. (NUTX) at the close on April 4, 2022, the earliest close on record here, it would have been worth $329 at the close on October 21, 2026: −96.71% in total, −52.79% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +20.04% |
| 2025 | +419.47% |
| 2024 | +17.37% |
| 2023 | −90.53% |
| 2022 (partial year) | −95.25% |
As of October 21, 2026.
NUTX Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $875.26M | $70.79M | 8.1% |
| 2024 | $479.95M | $52.10M | 10.9% |
| 2023 | $247.65M | −$45.79M | −18.5% |
| 2022 | $219.29M | −$424.78M | −193.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $875.26M | $444.28M | $275.63M | $70.79M | 8.1% |
| 2024 | $479.95M | $196.26M | $137.78M | $52.10M | 10.9% |
| 2023 | $247.65M | $34.77M | −$1.51M | −$45.79M | −18.5% |
| 2022 | $219.29M | $15.42M | −$4.58M | −$424.78M | −193.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
NUTX Valuation vs Medical Care Facilities Median
Median of 54 stocks| Metric | NUTX | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 7.83 | 20.67 | 62% below |
| P/S ratio | 1.60 | 0.87 | 84% above |
| Profit margin | 21.25% | 3.19% | 18.1 pts above |
Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Call
YahooHere's What Could Help Nutex Health (NUTX) Maintain Its Recent Price Strength
YahooNutex Health: A High-Risk, High-Reward Play For Speculative Investors
SeekingAlphaFreedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306
BenzingaCan Nutex Health (NUTX) Stay Undervalued As Earnings Shift?
YahooNutex Health (NUTX) Could Be 29% Undervalued As Nasdaq Texas Listing Nears
Yahoo
All 20 articles ↓Show fewer ↑
Nutex Health Remains A Bet On Reimbursement Policy
SeekingAlphaNutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)
SeekingAlphaNutex Health Approved for Dual Listing on Nasdaq Texas
YahooNutex Health Q2 2026 Earnings Call: Complete Transcript
BenzingaZacks.com featured highlights EuroDry, Vince Holding, Nutex, TXO Partners and KB Financial
YahooWhat Makes Nutex Health (NUTX) a Good Fit for 'Trend Investing'
YahooNUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT
YahooB. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325
BenzingaNutex Health Reports Data Exfiltration And Faces Class-Action Lawsuit Following Cyberattack, Filed August 27, 2026 In U.S. District Court, Houston; Complaint Seeks Damages, Injunctive Relief, Credit Monitoring, Identity Theft Insurance, Attorneys' Fees; Says Unable To Predict Outcome Of Litigation Or Estimate Incident Impact At This Stage
BenzingaNutex Health Inc. (NUTX) is a Great Momentum Stock: Should You Buy?
YahooNutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026
YahooNutex Health Confirms Certain Information On Its Servers Was Accessed, Exfiltrated By Unauthorized Third Party; No Material Impact Expected
BenzingaNUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS
YahooNutex Health Inc (NUTX) (Q2 2026) Earnings Call Highlights: Net Income Soars 3,100% as Revenue ...
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$99.46B
THCTenet Healthcare Corporation
$21.67B
EHCEncompass Health Corporation
$11.88B
FMSFresenius Medical Care AG
$11.47B
DVADaVita Inc.
$11.28B
UHSUniversal Health Services, Inc.
$10.78B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B














